The CBMS-Biosurveillance (BSV-Provisional) Office develops and integrates state-of-the-art chemical, biological, radiological, and nuclear (CBRN) technologies to enable early warning, identification, and situational awareness of potential global health threats. The CBMS-BSV's portfolio includes the Critical Reagents Program (CRP) and two diagnostic programs: 1) the Joint Biological Agent Identification and Diagnostic System (JBAIDS) and 2) the Next Generation Diagnostic System (NGDS).
The CRP features a collection of world-class reagents and assays used throughout the biodefense community world-wide, including interagency and international partners. The CRP products include robust pathogen and reference material
repositories, genomic materials, antigens, antibodies, polymerase chain reaction assays, electrochemiluminescence assays, system reagents, and lateral flow immunoassays.
JBAIDS Block I is the only DoD fielded U.S. Food and Drug Administration (FDA)-cleared deployable laboratory analytical system that provides the Warfighter with rapid on-site biological warfare (BW) agent and emerging infectious disease identification and medical diagnostic capabilities using polymerase chain reaction (PCR) technology. JBAIDS is a dual-purpose device for both surveillance and medical diagnostics, providing commanders' situational awareness to make informed decisions.
The NGDS is an evolutionary acquisition program to provide a family of identification and diagnostic capabilities across the echelons of care in the combat health support system. Increment 1 will be a rapid fielding effort to deliver the best available commercial off-the-shelf (COTS) capability to identify traditional, enhanced, emerging, and advanced biological threats (IOC FY13). The NGDS Increment 2 will transition revolutionary diagnostic technologies to provide additional point of care diagnostics, threat agnostic diagnostics, and host-response biomarker detection capabilities. Increment 2 will compliment NGDS 1.
Develop and integrate CBRN technologies to enable early warning, identification, and continued situational awareness of potential global health threats.
Joint Biological Agent Identification and Diagnostic System (JBAIDS)
Last updated: 8/28/2012 4:13:17 PM